Hematological malignancies.
Showing 3776 - 3800 of 3,813
Carcinoma of Unknown Primary Trial in Ann Arbor (Carboplatin, Gemcitabine, Capecitabine)
Terminated
- Carcinoma of Unknown Primary
- Carboplatin
- +2 more
-
Ann Arbor, MichiganUniversity of Michigan Comprehensive Cancer Center
Dec 28, 2007
Tumors, Hodgkin's Disease, Non-Hodgkin's Lymphoma Trial in Denver (TPI 287 Injection)
Completed
- Neoplasms
- +2 more
- TPI 287 Injection
-
Denver, ColoradoRocky Mountain Cancer Center
Oct 11, 2007
Relapsed Acute Promyelocytic Leukemia, Refractory Acute Promyelocytic Leukemia Trial in Mannheim (Arsenic trioxide, Trisenox)
Unknown status
- Relapsed Acute Promyelocytic Leukemia
- Refractory Acute Promyelocytic Leukemia
- Arsenic trioxide
- Trisenox
-
Mannheim, GermanyEva Lengfelder, MD, PhD
Oct 22, 2007
Leukemia, Lymphoma, Low-Grade, Lymphoma, Non-Hodgkin's Trial in Ann Arbor (Reduced intensity conditioning, Prophylactic donor
Terminated
- Leukemia
- +4 more
- Reduced intensity conditioning
- Prophylactic donor leukocyte infusions
-
Ann Arbor, MichiganThe University of Michigan
Apr 20, 2007
Chronic Myeloid Leukemia Trial in Bologna (STI571 (400 mg/day; or 800 mg/day))
Completed
- Chronic Myeloid Leukemia
- STI571 (400 mg/day; or 800 mg/day)
-
Bologna, ItalyIstituto di Ematologia e Oncologia Medica "L. e A. Seràgnoli"
Aug 9, 2007
Malignancies, Lymphoma Trial in Birmingham (CS-1008 (humanized anti-DR5 antibody))
Completed
- Malignancies
- Lymphoma
- CS-1008 (humanized anti-DR5 antibody)
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Sep 10, 2007
Liver Cancer Trial in Larisa (Hexablate)
Unknown status
- Liver Cancer
- Hexablate
-
Larisa, GreeceC. Hatzitheofilou
Aug 9, 2007
Acute Promyelocytic Leukemia Trial in India (Single agent arsenic trioxide)
Unknown status
- Acute Promyelocytic Leukemia
- Single agent arsenic trioxide
-
Bangalore, Karnataka, India
- +8 more
Aug 16, 2007
Ovarian Cancer Trial in Taipei (venous puncture)
Unknown status
- Ovarian Cancer
- venous puncture
-
Taipei, TaiwanNational Taiwan Univ. Hospital
Aug 10, 2007
Tumors Trial in Jerusalem (Cell therapy)
Unknown status
- Tumors
- Cell therapy
-
Jerusalem, IsraelHadassah Medical Organization
Mar 13, 2007
Malignant Disease, Evaluated by Thrombelastograph (TEG®)
Unknown status
- Cancer
-
Copenhagen, DenmarkRigshospitalet
Nov 16, 2006
Mesothelin Antigen Specific Immunologic Assays in Ovarian Cancer
Unknown status
- Ovarian Cancer
-
Taipei, TaiwanNational Taiwan University Hospital
Dec 18, 2006
Human Papillomavirus Type 16 E7-Specific Immune Response
Unknown status
- Cervical Cancer
-
Taipei, TaiwanNational Taiwan University Hospital
Dec 20, 2006
Haplotype of Human Leukocyte Antigen and Human Papillomavirus
Unknown status
- Cancer of Cervix
-
Taipei, TaiwanWen-Fang Cheng
Dec 13, 2006
Multiple Myeloma, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial (Human Growth hormone)
Completed
- Multiple Myeloma
- +3 more
- Human Growth hormone
- (no location specified)
Oct 12, 2006
Malignant Hemopathy, Duration of Neutropenia Following Chemo > 10 Days Trial in Paris (Amphotericin B)
Terminated
- Malignant Hemopathy
- Duration of Neutropenia Following Chemotherapy > 10 Days
- Amphotericin B
-
Paris, Ile de France, FranceChu Henri Mondor
Sep 20, 2006
Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia Trial in Denver (Cord Blood Transplant)
Unknown status
- Acute Myeloid Leukemia
- +4 more
- Cord Blood Transplant
-
Denver, ColoradoRocky Mountain Blood and Marrow Transplant Program
Jun 23, 2006
Proton Magnetic Resonance Spectroscopy in Evaluating Bone
Unknown status
- Acquired Immunodeficiency Syndrome
- Lipodystrophy
-
Taipei, TaiwanTiffany Ting-Fang Shih
Mar 28, 2006
The Development of Human Papillomavirus Type 16 E7-Specific
Unknown status
- Cervical Cancer
-
Taipei, TaiwanNational Taiwan University Hospital
Dec 19, 2005